NICHOLAS DONATO: Open Payments
NPI 1154095669 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$544 in 13 payments from 8 companies in 2025. Trend: 2023 $504 · 2024 $288 · 2025 $544
Food & beverage: $544
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 4 | $190 |
| Amgen Inc. | 1 | $102 |
| BeOne Medicines USA, Inc. | 1 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $53 |
| Genentech USA, Inc. | 1 | $31 |
| Celgene Corporation | 1 | $27 |
| ABBVIE INC. | 1 | $24 |
| Janssen Scientific Affairs, LLC | 1 | $23 |
Products named: SARCLISA, KYPROLIS, BRUKINSA, NINLARO, Polivy, BREYANZI, VENCLEXTA, TECVAYLI.
Industry payments across OH — which companies pay providers there.
